Hemeralopia (Progressive Retinal Atrophy)
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
Learn what the condition is, how it may be detected early, how it is treated or managed, and which breeds or species are linked to it.
A concise guide to the condition’s pattern, detection, management and urgency.
This snapshot is a general guide, not a diagnosis or treatment plan. New, severe or worsening signs require veterinary assessment.
Hemeralopia is an inherited retinal disorder that primarily affects cone photoreceptor cells. Cones are responsible for vision in bright light and for fine visual detail. Rod photoreceptors, which support vision in dim light, are relatively preserved in the forms traditionally described in dogs. The result is a distinctive pattern of day blindness: an affected dog can navigate more successfully in dim conditions but struggles when lighting is bright.
Signs generally begin early, often during puppyhood or before one year of age. Owners may notice the dog bumping into objects outside on sunny days, hesitating in brightly lit areas, misjudging steps or seeming much more confident at dusk or indoors. The contrast with ordinary progressive retinal atrophy is important because generalised PRA usually affects rod function first, producing night blindness before daytime vision deteriorates.
Hemeralopia has been inherited as an autosomal recessive condition in studied breed populations. Other breeds may have clinically similar disease with a different genetic basis.
The condition is generally non-painful. Its main effect is functional vision loss in bright environments and the safety issues that follow. Many affected dogs adapt well when their surroundings are predictable, but they need protection from situations in which sudden loss of visual confidence could place them at risk.
Owners may notice that an affected dog hesitates, collides with objects or appears disoriented outdoors in bright conditions while navigating much more confidently in dimmer surroundings.
Autosomal recessive inheritance allows clinically normal carriers to pass the mutation to offspring and produce affected puppies when paired together. Other causes of visual impairment, including cataract, retinal inflammation and generalised PRA, need to be distinguished. Report light-dependent visual behaviour rather than waiting for obvious retinal degeneration.
Where a validated DNA test exists for the breed-specific form of hemeralopia, genetic screening is the best method for identifying clear dogs, carriers and genetically affected animals before clinical signs are obvious.
In breeds without a DNA test, early detection relies on observing visual behaviour. Puppies and young dogs should be watched for a consistent difference between bright-light and dim-light navigation. A dog that repeatedly bumps into obstacles outdoors in strong light but moves confidently at dusk deserves ophthalmic assessment.
A veterinary ophthalmologist can examine the retina and may recommend electroretinography. ERG is valuable because it tests the functional response of rods and cones separately and can detect cone dysfunction even when visible retinal changes are subtle.
A normal-looking eye at a routine general examination does not exclude hemeralopia. Screening should occur before breeding in affected lines, using DNA testing when available and specialist eye examination when it is not.
Mutations and DNA tests have been described for selected breeds, including forms in the Alaskan Malamute and German Shorthaired Pointer. Veterinary ophthalmic examination can identify retinal changes, but early in disease the eye may not look dramatically abnormal. Electroretinography is particularly useful because it measures the retina’s electrical response to light and can demonstrate reduced cone function. DNA testing can confirm a known breed-specific mutation when available.
Inherited hemeralopia cannot currently be treated in a way that restores normal cone photoreceptor function, so management focuses on safe adaptation to day blindness. Management therefore focuses on helping the dog use its remaining vision safely and confidently. Because dim-light vision is relatively preserved, many affected dogs function well indoors and in lower-light environments and can maintain a good quality of life.
Owners can reduce risk by keeping the home layout consistent, avoiding sudden obstacles and using a lead in unfamiliar or very bright places. High-contrast markers at steps or doorways may help some dogs. Bright glare can be particularly challenging, so walks can be scheduled for early morning or evening when practical. Dogs should not be allowed off lead near roads, cliffs, water hazards or other areas where a visual mistake could have serious consequences.
Routine eye checks remain important because an affected dog can still develop unrelated painful ocular disease. New redness, squinting or sudden deterioration should not be attributed automatically to hemeralopia, which itself is not typically painful.
There is no evidence that vitamin supplementation, eye drops or other routine medications can reverse the inherited retinal degeneration. The focus should remain on adaptation rather than unproven attempts to restore vision.
Adaptation is usually very successful when the dog’s environment is predictable. Routine veterinary eye checks remain useful because redness, squinting or sudden deterioration can indicate a separate painful eye problem that should not be dismissed as part of the inherited day blindness.
Alaskan malamute
Open dog breed description, care requirements and conditions
Dachshund
Open dog breed description, care requirements and conditions
German shorthaired pointer
Open dog breed description, care requirements and conditions
Great Dane
Open dog breed description, care requirements and conditions
Miniature Poodle
Open dog breed description, care requirements and conditions
Poodle (standard)
Open dog breed description, care requirements and conditions